nitrosobis(2-oxopropyl)amine has been researched along with loxiglumide in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Miyazaki, N; Saito, Y; Tomioka, M; Yamamoto, M | 1 |
Itho, M; Matsuda, S; Ogura, Y; Sasaki, H; Shimomura, M; Tanigawa, K | 1 |
2 other study(ies) available for nitrosobis(2-oxopropyl)amine and loxiglumide
Article | Year |
---|---|
[Effect of combined use of CR1505 with UFT for the tumor growth of the subcutaneously transplanted pancreatic cancer in the Syrian golden hamsters].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Division; Cholecystokinin; Cricetinae; Mesocricetus; Neoplasm Transplantation; Nitrosamines; Pancreatic Neoplasms; Proglumide; Tegafur; Uracil | 1993 |
Inhibitory effect of loxiglumide (CR 1505), a cholecystokinin receptor antagonist, on N-nitrosobis(2-oxopropyl) amine-induced biliary carcinogenesis in Syrian hamsters.
Topics: Adenocarcinoma, Papillary; Animals; Autoradiography; Biliary Tract Neoplasms; Carcinogens; Cholecystectomy, Laparoscopic; Cricetinae; Disease Models, Animal; Duodenostomy; Female; Hormone Antagonists; Mesocricetus; Nitrosamines; Proglumide; Radiography; Receptors, Cholecystokinin | 2002 |